Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €6.24B | 38.3x | €7.05 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Grifols | Madrid | Healthcare | Pharmaceuticals | €6.24B | 38.3x | €9.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €3.15B | 19.9x | €61.40 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.4% Upside | Upgrade to Pro+ | ||
Almirall | Madrid | Healthcare | Pharmaceuticals | €1.73B | -38.5x | €8.08 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.8% Upside | Upgrade to Pro+ | ||
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €1.34B | 2,190x | €76.70 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | ||
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.08B | 11x | €3.45 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.7% Upside | Upgrade to Pro+ | ||
Clinica Baviera | Madrid | Healthcare | Healthcare Providers & Services | €498.78M | 13.4x | €31.20 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Natac Natural Ingredients | Madrid | Healthcare | Pharmaceuticals | €295.67M | -39.2x | €0.68 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Atrys Health | Madrid | Healthcare | Healthcare Providers & Services | €265.02M | -6.8x | -0.78 | €3.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €201.75M | 21.2x | €2.53 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Prim | Madrid | Healthcare | Healthcare Equipment & Supplies | €168.12M | 14.7x | 0.88 | €9.88 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oryzon Genomics | Madrid | Healthcare | Biotechnology & Medical Research | €90.89M | -20.9x | -6.5 | €1.44 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pangaea Oncology | Madrid | Healthcare | Biotechnology & Medical Research | €60.12M | -10x | 0.12 | €1.75 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €20.14M | -11.7x | -0.2 | €3.02 | 5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -16.1% Downside | Upgrade to Pro+ | |
Biotechnology Assets | Madrid | Healthcare | Biotechnology & Medical Research | €17.50M | -5.7x | 0.03 | €0.27 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Euroespes S.A. | Madrid | Healthcare | Healthcare Providers & Services | €3.67M | -3.2x | €0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |